| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 315 |
| 1 | ASPIRIN 325 MG | 312 |
| 2 | ASPIRIN 81 MG | 312 |
| 3 | METFORMIN | 289 |
| 4 | ESOMEPRAZOLE MAGNESIUM | 282 |
| 5 | IRBESARTAN | 281 |
| 6 | SITAGLIPTIN | 269 |
| 7 | ATORVASTATIN CALCIUM | 253 |
| 8 | ALISKIREN HEMIFUMARATE | 250 |
| 9 | ESOMEPRAZOLE | 246 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE | 4 | 0.2857 |
| 1 | COAL TAR | 177 | 0.2305 |
| 2 | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | 1 | 0.1000 |
| 3 | TAFENOQUINE | 3 | 0.0500 |
| 4 | ALISKIREN HEMIFUMARATE | 250 | 0.0420 |
| 5 | ACITRETIN | 181 | 0.0378 |
| 6 | CLOTRIMAZOLE1% CLOTRIMAZOLE | 1 | 0.0182 |
| 7 | METHYLPREDNISOLONE ACETATE | 134 | 0.0172 |
| 8 | SITAGLIPTIN PHOSPHATE | 44 | 0.0168 |
| 9 | DIMENHYDRINATE | 156 | 0.0150 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 407 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 317 |
| 2 | Angiotensin 2 Receptor Blocker [EPC] | 308 |
| 3 | Proton Pump Inhibitor [EPC] | 291 |
| 4 | Corticosteroid [EPC] | 265 |
| 5 | Vitamin B12 [EPC] | 218 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 199 |
| 7 | Provitamin D2 Compound [EPC] | 199 |
| 8 | Retinoid [EPC] | 198 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 191 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Phenothiazine [EPC] | 157 | 0.0054 |
| 1 | Tubulin Inhibiting Agent [EPC] | 1 | 0.0035 |
| 2 | Ileal Bile Acid Transporter Inhibitor [EPC] | 1 | 0.0033 |
| 3 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 4 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |
| 5 | Dietary Cholesterol Absorption Inhibitor [EPC] | 161 | 0.0018 |
| 6 | Histamine-1 Receptor Antagonist [EPC] | 133 | 0.0016 |
| 7 | Interleukin-12 Antagonist [EPC] | 161 | 0.0016 |
| 8 | Serotonin-3 Receptor Antagonist [EPC] | 166 | 0.0013 |
| 9 | Leukotriene Receptor Antagonist [EPC] | 32 | 0.0012 |